Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 422

Similar articles for PubMed (Select 23791547)


Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.

Connie Leung YH, Luk G, Sia SF, Wu YO, Ho CK, Chow KC, Tang SC, Guan Y, Malik Peiris JS.

Vaccine. 2013 Aug 2;31(35):3536-42. doi: 10.1016/j.vaccine.2013.05.076. Epub 2013 Jun 19.


nextflu: real-time tracking of seasonal influenza virus evolution in humans.

Neher RA, Bedford T.

Bioinformatics. 2015 Jun 26. pii: btv381. [Epub ahead of print]


Informal inter-island poultry movement in Indonesia: does it pose a risk to HPAI H5N1 transmission?

Millar J, Abdurrahman M, Toribio JA, Ambarawati A, Yusuf RP, Suadnya W.

Trop Anim Health Prod. 2015 Jun 20. [Epub ahead of print]


Low Virulence and Lack of Airborne Transmission of the Dutch Highly Pathogenic Avian Influenza Virus H5N8 in Ferrets.

Richard M, Herfst S, van den Brand JM, Lexmond P, Bestebroer TM, Rimmelzwaan GF, Koopmans M, Kuiken T, Fouchier RA.

PLoS One. 2015 Jun 19;10(6):e0129827. doi: 10.1371/journal.pone.0129827. eCollection 2015.


A cyclophosphamide-sensitive cell compartment is essential for homologous protection conferred by licensed vaccines for the control of avian pathogenic Escherichia coli in chickens.

Sadeyen JR, Kaiser P, Stevens MP, Dziva F.

Vaccine. 2015 Jul 17;33(31):3624-7. doi: 10.1016/j.vaccine.2015.06.034. Epub 2015 Jun 16.


Highly Pathogenic Avian Influenza A(H5N1) Virus in Poultry, Nigeria, 2015.

Monne I, Meseko C, Joannis T, Shittu I, Ahmed M, Tassoni L, Fusaro A, Cattoli G.

Emerg Infect Dis. 2015 Jul;21(7):1275-7. doi: 10.3201/eid2107.150421. No abstract available.


Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.

Long J, Wright E, Molesti E, Temperton N, Barclay W.

Version 2. F1000Res. 2015 Jan 29 [revised 2015 Feb 10];4:30. doi: 10.12688/f1000research.6085.2. eCollection 2015.


Complete Genome Sequence of a Highly Pathogenic Avian Influenza Virus (H5N2) Associated with an Outbreak in Commercial Chickens, Iowa, USA, 2015.

Clement T, Kutish GF, Nezworski J, Scaria J, Nelson E, Christopher-Hennings J, Diel DG.

Genome Announc. 2015 Jun 11;3(3). pii: e00613-15. doi: 10.1128/genomeA.00613-15.


Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens.

Bertran K, Thomas C, Guo X, Bublot M, Pritchard N, Regan JT, Cox KM, Gasdaska JR, Dickey LF, Kapczynski DR, Swayne DE.

Vaccine. 2015 Jul 9;33(30):3456-62. doi: 10.1016/j.vaccine.2015.05.076. Epub 2015 Jun 9.


Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus.

Gari G, Abie G, Gizaw D, Wubete A, Kidane M, Asgedom H, Bayissa B, Ayelet G, Oura CA, Roger F, Tuppurainen ES.

Vaccine. 2015 Jun 22;33(28):3256-61. doi: 10.1016/j.vaccine.2015.01.035.


Molecular characterization of H9N2 avian influenza viruses isolated from vaccinated broiler chickens in northeast Iran.

Bahari P, Pourbakhsh SA, Shoushtari H, Bahmaninejad MA.

Trop Anim Health Prod. 2015 Jun 9. [Epub ahead of print]


Prevention of nosocomial transmission of influenza A (H7N9) in Hong Kong.

Cheng VC, Lee WM, Sridhar S, Ho PL, Yuen KY.

J Hosp Infect. 2015 Aug;90(4):355-6. doi: 10.1016/j.jhin.2015.04.016. Epub 2015 May 15. No abstract available.


Using combinatorial bioinformatics methods to analyze annual perspective changes of influenza viruses and to accelerate development of effective vaccines.

Hu YJ, Chow KC, Liu CC, Lin LJ, Wang SC, Wang S.

J Formos Med Assoc. 2015 Jun 1. pii: S0929-6646(15)00146-1. doi: 10.1016/j.jfma.2015.03.018. [Epub ahead of print]


An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.

Leung HC, Chan CC, Poon VK, Zhao HJ, Cheung CY, Ng F, Huang JD, Zheng BJ.

Emerg Microbes Infect. 2015 Apr;4(4):e22. doi: 10.1038/emi.2015.22. Epub 2015 Apr 8.


Pathobiological features of a novel, highly pathogenic avian influenza A(H5N8) virus.

Kim YI, Pascua PN, Kwon HI, Lim GJ, Kim EH, Yoon SW, Park SJ, Kim SM, Choi EJ, Si YJ, Lee OJ, Shim WS, Kim SW, Mo IP, Bae Y, Lim YT, Sung MH, Kim CJ, Webby RJ, Webster RG, Choi YK.

Emerg Microbes Infect. 2014 Oct;3(10):e75. doi: 10.1038/emi.2014.75. Epub 2014 Oct 22.


Protease activation mutants elicit protective immunity against highly pathogenic avian influenza viruses of subtype H7 in chickens and mice.

Wagner R, Gabriel G, Schlesner M, Alex N, Herwig A, Werner O, Klenk HD.

Emerg Microbes Infect. 2013 Feb;2(2):e7. doi: 10.1038/emi2013.7. Epub 2013 Feb 27.


Silent geographical spread of the H7N9 virus by online knowledge analysis of the live bird trade with a distributed focused crawler.

Chen C, Lu S, Du P, Wang H, Yu W, Song H, Xu J.

Emerg Microbes Infect. 2013 Dec;2(12):e89. doi: 10.1038/emi.2013.91. Epub 2013 Dec 18.


Assessing the fitness of distinct clades of influenza A (H9N2) viruses.

SJCEIRS H9 Working Group.

Emerg Microbes Infect. 2013 Nov;2(11):e75. doi: 10.1038/emi.2013.75. Epub 2013 Nov 6.


Avian influenza A H5N1 virus: a continuous threat to humans.

To KK, Ng KH, Que TL, Chan JM, Tsang KY, Tsang AK, Chen H, Yuen KY.

Emerg Microbes Infect. 2012 Sep;1(9):e25. doi: 10.1038/emi.2012.24. Epub 2012 Sep 19. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk